Miraqules offers the StopBleed program, which provides training and essential tools for individuals and first responders to manage traumatic bleeding incidents effectively. This program addresses the urgent need for immediate hemorrhage control, potentially saving lives before professional medical assistance arrives.
Funding
$27.9K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Uncontrolled bleeding from traumatic injuries is a leading cause of preventable deaths, particularly in pre-hospital settings and when injuries are non-compressible or not amenable to tourniquet application. Current hemostatic solutions often lack the speed and efficacy needed to manage severe bleeding effectively in emergency situations.
Solution
Miraqules MedSolutions develops fast-acting anti-bleeding solutions designed for rapid hemorrhage control in emergency bleeding situations. Their patented StopBleed products utilize biomaterials that structurally resemble naturally occurring fibrin threads, enhancing their effectiveness compared to existing hemostats. The StopBleed compound can be formulated into different forms, such as powder and pellets, to suit various application areas and overcome application challenges, providing a versatile solution for rapid bleeding control.
Target Audience
The primary target audience includes first responders, emergency medical personnel, hospitals, primary health centers, poly-clinics, and individuals seeking effective solutions for managing traumatic bleeding incidents.
Features
- Patented biomaterial fabrication process that mimics the structure of naturally occurring fibrin threads
- StopBleed Powder: Ideal for irregular and complex wounds
- StopBleed Pro: Designed for targeted and precise delivery in narrow entry wounds using an applicator and individual pallets
- Demonstrated ability to arrest post-trauma bleeding in approximately 40 seconds
- Hemostatic agents are designed to be five times more effective than existing solutions
- Developing techniques to speed up the healing process and minimize scar formation